SCHEMBL15728982

SCHEMBL15728982

C[C@@H](N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1)C(=O)O

nearest known ligand 0.86

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.86
CYP2C9 P11712 2/20 0.86
P2RY2 P41231 9/20 0.47
P2RY6 Q15077 6/20 0.47
P2RY14 Q15391 2/20 0.47
P2RY4 P51582 3/20 0.47
POLA1 P09884 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17451182 1.00 CYP3A4 (0.86) CYP3A4CYP2C9P2RY2P2RY6P2RY14
SCHEMBL19283470 1.00 CYP3A4 (0.86) CYP3A4CYP2C9P2RY2P2RY6P2RY14
SCHEMBL15876420 1.00 CYP3A4 (0.86) CYP3A4CYP2C9P2RY2P2RY6P2RY14
SCHEMBL15876419 1.00 CYP3A4 (0.86) CYP3A4CYP2C9P2RY2P2RY6P2RY14
SCHEMBL2525660 1.00 CYP3A4 (0.86) CYP3A4CYP2C9P2RY2P2RY6P2RY14
SCHEMBL3755009 1.00 CYP3A4 (0.86) CYP3A4CYP2C9P2RY2P2RY6P2RY14
SCHEMBL2525662 1.00 CYP3A4 (0.86) CYP3A4CYP2C9P2RY2P2RY6P2RY14
SCHEMBL2525665 1.00 CYP3A4 (0.86) CYP3A4CYP2C9P2RY2P2RY6P2RY14
SCHEMBL3755012 1.00 CYP3A4 (0.86) CYP3A4CYP2C9P2RY2P2RY6P2RY14
SCHEMBL28720279 0.95 CYP3A4 (0.79) CYP3A4CYP2C9P2RY2P2RY6P2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014078436-A1 D-ALANINE ESTER OF SP-NUCLEOSIDE ANALOG IDENIX PHARMACEUTICALS, INC. (US) 2014-05-22 WO disclosed
US-20110236903-A1 MATERIALS AND METHODS FOR DETERMINING DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2011-09-29 US disclosed